DEVELOPING THE FRAMEWORK FOR FIRST-IN-CLASS IMMUNOTHERAPIES THAT TARGET DISSEMINATED TUMOR CELLS AND PREVENT BREAST CANCER METASTASIS

Fred Hutchinson Cancer Center, Seattle WA

Investigators